Simon Barry J.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$13.38M

Insider Activity of Simon Barry J.

The largest sale of all time was on 2020-12-22 and amounted to 130000 shares of ImmunityBio, Inc. for $2.35M.

Biography of Simon Barry J.

No biography is available at this moment.

2021-05-25SaleImmunityBio, Inc.
IBRX
director
88,787
0.0237%
$16.18$1.44M-54.64%
2021-05-24SaleImmunityBio, Inc.
IBRX
director
21,223
0.0056%
$16.02$340,071-54.46%
2021-05-21SaleImmunityBio, Inc.
IBRX
director
14,990
0.0039%
$16.09$241,164-53.43%
2021-02-05SaleImmunityBio, Inc.
IBRX
See remarks
22,100
0.0056%
$23.09$510,267-52.76%
2021-02-02SaleImmunityBio, Inc.
IBRX
See remarks
82,070
0.0212%
$20.65$1.69M-46.1%
2021-01-28SaleImmunityBio, Inc.
IBRX
See remarks
11,304
0.0033%
$20.53$232,121-39.34%
2021-01-27SaleImmunityBio, Inc.
IBRX
See remarks
36,626
0.01%
$20.61$754,946-42.76%
2020-12-22SaleImmunityBio, Inc.
IBRX
See remarks
130,000
0.1231%
$18.05$2.35M-22.23%
2020-07-21SaleImmunityBio, Inc.
IBRX
See remarks
1,565
0.0004%
$15.50$24,258-8.14%
2020-07-20SaleImmunityBio, Inc.
IBRX
See remarks
128,435
0.0339%
$15.53$2M-8.79%
2020-07-08SaleImmunityBio, Inc.
IBRX
See remarks
39,950
0.0091%
$13.14$524,759-5.77%
2020-06-30SaleImmunityBio, Inc.
IBRX
See remarks
9
<0.0001%
$13.00$117+15.02%
2020-06-23SaleImmunityBio, Inc.
IBRX
See remarks
29,609
0.0085%
$13.01$385,133+16.82%
2020-06-22SaleImmunityBio, Inc.
IBRX
See remarks
156,695
0.0376%
$10.24$1.6M+23.72%
2020-06-19SaleImmunityBio, Inc.
IBRX
See remarks
13,737
0.0037%
$9.00$123,637+55.77%
2020-05-27SaleImmunityBio, Inc.
IBRX
See remarks
75,000
0.0195%
$7.56$567,338+62.93%
2020-05-21SaleImmunityBio, Inc.
IBRX
See remarks
36,932
0.0093%
$5.52$203,698+111.36%
2020-05-11SaleImmunityBio, Inc.
IBRX
See remarks
28,068
0.0078%
$5.50$154,509+116.18%
2016-09-08SaleImmunityBio, Inc.
IBRX
President and COO
30,000
0.0306%
$7.40$222,000-32.48%
2016-09-07SaleImmunityBio, Inc.
IBRX
President and COO
2,000
0.0024%
$8.84$17,671-32.71%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.